The present study demonstrates that FTZ extracts inhibit NASH by its action on both inflammatory response and lipid metabolism associated with NLRP3 inflammasome activation in the liver. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.